Bryan Lewis, who serves as Chief Executive Officer and President of Intellicheck, Inc. (NASDAQ: IDN), executed a sale of 10,000 shares of the company’s common stock on April 20, 2026. The aggregate proceeds from the transaction amounted to $85,145.
The shares were sold at a weighted average price of $8.5145 per share, with recorded execution prices ranging from $8.39 to $8.63. The disposition was carried out through The Lewis Family Revocable Living Trust and was conducted under a Rule 10b5-1 trading arrangement adopted by the trust on December 17, 2025. The plan specifies a selling window that began on April 6, 2026, and will conclude on July 31, 2026. Mr. Lewis has stated that he disclaims beneficial ownership of the shares except to the extent of his pecuniary interest.
Following this sale, Mr. Lewis retains an indirect holding of 50,000 shares of Intellicheck common stock.
The transaction took place as Intellicheck shares were trading at $8.68, near the stock’s 52-week high. Over the prior 12-month period the share price has risen approximately 272%. An InvestingPro analysis cited in company commentary indicates the stock appears overvalued relative to its Fair Value estimate and notes additional valuation metrics and investor guidance available on the platform, including 18 extra ProTips.
Separately, Intellicheck reported financial results for the fourth quarter of 2025 that outpaced consensus estimates. The company posted earnings per share of $0.08, versus a forecast of $0.0233. Revenue for the quarter was $6.635 million, ahead of a projected $6.2 million, and the company described the quarter and full year revenue totals as record levels. Retail revenue rose 25% quarter-over-quarter, which the company identified as a material contributor to the revenue outperformance.
In response to the stronger-than-expected results, two sell-side firms maintained positive coverage. DA Davidson reiterated a Buy rating for Intellicheck with a price target of $7.50. H.C. Wainwright also reiterated a Buy recommendation and set a price target of $8.50, citing the revenue beat. These analyst actions were presented as supporting a constructive outlook on the company’s recent performance.
Clear summary: The Intellicheck CEO sold 10,000 shares for $85,145 on April 20, 2026, via a 10b5-1 plan established by The Lewis Family Revocable Living Trust. The sale coincided with a significant recent run in the stock, which is trading near its 52-week high after a 272% one-year gain, and followed a quarterly earnings and revenue beat that prompted repeated Buy ratings from DA Davidson and H.C. Wainwright.
Key points:
- Executive sale: Bryan Lewis sold 10,000 shares at a weighted average price of $8.5145, with prices between $8.39 and $8.63, under a Rule 10b5-1 plan.
- Stock context: Intellicheck shares were trading at $8.68, near a 52-week high, after a 272% increase over the prior year.
- Financials and analyst reaction: Q4 2025 EPS of $0.08 and revenue of $6.635 million beat forecasts; DA Davidson and H.C. Wainwright reiterated Buy ratings with $7.50 and $8.50 targets, respectively.
Risks and uncertainties:
- Valuation concern: InvestingPro analysis indicates the stock may be overvalued relative to its Fair Value estimate, introducing potential downside risk for equity investors.
- Insider disposition timing: The sale occurred under a pre-established 10b5-1 plan, but insider selling can be perceived variably by the market and may impact near-term sentiment.
- Reliance on retail growth: A 25% quarter-over-quarter increase in retail revenue supported the beat; future revenue performance may hinge on sustaining that retail momentum.